High-dose Methylprednisolone/Rituximab Regimen

Preferred Label : High-dose Methylprednisolone/Rituximab Regimen;

NCIt synonyms : Rituximab-High-dose Methylprednisolone; Rituximab/High-dose Methylprednisolone Regimen; Rituximab Plus High-dose Methylprednisolone; HDMP/Rituximab Regimen; High-dose Methylprednisolone/Rituximab; High-dose Methylprednisolone-Rituximab; Rituxan/HDMP; High-dose Methylprednisolone-Rituximab Regimen; Rituximab/HDMP; HDMP-R;

NCIt related terms : HDMP-R (rituximab-abbs); HDMP-R (rituximab-arrx); HDMP-R (rituximab-blit); HDMP-R (rituximab-rixa); HDMP-R (rituximab-rixi); HDMP-R (rituximab-rite); HDMP-R (rituximab-pvvr);

NCIt definition : A regimen consisting of high-dose methylprednisolone (HDMP) and rituximab that can be used for the treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).;

NCI Metathesaurus CUI : CL1664352;

Codes from synonyms : 127741; 12113; 128055; 128212; 128369; 127898; 128526; 128683;

Détails

Origin ID

C181202;

UMLS CUI

C5556902;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Methylprednisolone Sodium Succinate [NCIt concept]
- Rituximab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients